Atlas Trials

Select Advanced Malignancies

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Select Advanced Malignancies

RecordFirmDate
A Phase 1/2, Open-label Study to Evaluate the Safety and Antitumor Activity of MEDI0680 (AMP-514) in Combination With Durvalumab Versus Nivolumab Monotherapy in Participants With Select Advanced Malignancies (NCT02118337)MedImmune LLC2014-05-19

Track Select Advanced Malignancies automatically

Every clearance here is in the API, with alerts when new ones post.